Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.

The myelodysplastic syndromes are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia in one or more cell lineages and increased risk of evolution to acute myeloid leukemia (AML). Recent advances in immunophenotyping of hematopoietic progenitor and maturing ce...

ver descrição completa

Detalhes bibliográficos
Main Authors:	van de Loosdrecht, A, Alhan, C, Béné, M, Della Porta, MG, Dräger, A, Feuillard, J, Font, P, Germing, U, Haase, D, Homburg, C, Ireland, R, Jansen, J, Kern, W, Malcovati, L, Te Marvelde, J, Mufti, G, Ogata, K, Orfao, A, Ossenkoppele, G, Porwit, A, Preijers, F, Richards, S, Schuurhuis, G, Subirá, D, Valent, P
Formato:	Journal article
Idioma:	English
Publicado em:	2009

Registos relacionados

Characterisation of Myeloid, Lymphiod and Erythroid Cell Lineages in Myelodysplastics Syndrome Using Flow Cytometry
Por: Broojerdi, Mohadese Hashem
Publicado em: (2011)

MULTICENTRE VALIDATION OF A REPRODUCIBLE FLOW CYTOMETRIC SCORE FOR THE DIAGNOSIS OF LOWRISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A EUROPEAN LeukemiaNET STUDY
Por: Picone, C, et al.
Publicado em: (2011)

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study.
Por: Della Porta, MG, et al.
Publicado em: (2012)

Angiogenesis in myelodysplastic syndromes.
Por: Pruneri, G, et al.
Publicado em: (1999)

Clonality in the myelodysplastic syndromes.
Por: Boultwood, J, et al.
Publicado em: (2001)

Molecular pathogenesis of the myelodysplastic syndromes
Por: Boultwood, J, et al.
Publicado em: (1999)

Telomere length in myelodysplastic syndromes.
Por: Boultwood, J, et al.
Publicado em: (1997)

Telomere length in myelodysplastic syndromes.
Por: Boultwood, J, et al.
Publicado em: (1995)

Hematologic malignancies : myelodysplastic syndromes /
Por: Deeg, H. Joachim (Hans Joachim), 1945-
Publicado em: (2006)

Gene expression profiling in the myelodysplastic syndromes.
Por: Pellagatti, A, et al.
Publicado em: (2005)

Luspatercept in patients with lower-risk myelodysplastic syndromes
Por: Fenaux, P, et al.
Publicado em: (2020)

Acquired alpha thalassaemia in myelodysplastic syndrome
Por: Cheong, P
Publicado em: (2018)

Cytogenetic clonal evolution In myelodysplastic syndrome
Por: Aw, Eunice Ching-Yi
Publicado em: (2018)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
Por: Pellagatti, A, et al.
Publicado em: (2003)

Guidelines for the diagnosis and management of adult myelodysplastic syndromes.
Por: Killick, S, et al.
Publicado em: (2014)

Guidelines for the diagnosis and management of adult myelodysplastic syndromes
Por: Killick, S, et al.
Publicado em: (2014)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
Por: Malcovati, L, et al.
Publicado em: (2011)

Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia.
Por: Watson, A, et al.
Publicado em: (2011)

Trisomy X and myelodysplastic syndrome (MDS) with eosinophilia
Por: Mohd Tohit, Eusni Rahayu, et al.
Publicado em: (2012)

α-Thalassemia, mental retardation, and myelodysplastic syndrome.
Por: Gibbons, R
Publicado em: (2012)

Characterisation and targeting of stem cells in myelodysplastic syndromes
Por: Chowdhury, O
Publicado em: (2013)

Characterization of the hemopoietic defect in early stages of the myelodysplastic syndromes.
Por: Vyas, P, et al.
Publicado em: (2006)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
Por: Boultwood, J, et al.
Publicado em: (2014)

Clinical and biological implications of driver mutations in myelodysplastic syndromes.
Por: Papaemmanuil, E, et al.
Publicado em: (2013)

Flow cytometry in microbiology/
Por: Lloyd, David
Publicado em: (1993)

Introduction to flow cytometry /
Por: 395027 Watson, James V.
Publicado em: (2004)

Molecular Cytogenetics Of Myelodysplastic Syndrome – Hospital Based Study
Por: Isa, Asmida
Publicado em: (2014)

Myelodysplastic syndrome due to somatic GATA1 mutation.
Por: Freson, K, et al.
Publicado em: (2004)

Study of chromosomal aberrations in Myelodysplastic syndrome in an Asian population
Por: Cheah, Grace Yee May
Publicado em: (2015)

An investigation of the role of mutations in the spliceosome machinery in the myelodysplastic syndromes
Por: Lee, J
Publicado em: (2022)

Qualitative flow cytometric analysis of Malaysian myelodysplastic syndromes (MDS) patients.
Por: Broojerdi, Mohadese Hashem, et al.
Publicado em: (2012)

Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes.
Por: Roy, N, et al.
Publicado em: (2011)

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
Por: Armstrong, R, et al.
Publicado em: (2017)

SF3B1 mutant myelodysplastic syndrome: Recent advances
Por: Pellagatti, A, et al.
Publicado em: (2020)

Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome
Por: Galili, Naomi, et al.
Publicado em: (2012)

Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
Por: Goh, Chermaine Yu Zhen
Publicado em: (2021)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
Por: Pellagatti, A, et al.
Publicado em: (2009)

Flow cytometry : principles and applications /
Por: Macey, Marion G.
Publicado em: (2007)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
Por: Pellagatti, A, et al.
Publicado em: (2010)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
Por: Pellagatti, A, et al.
Publicado em: (2008)